Orthofix Medical (OFIX) Other Accumulated Expenses (2010 - 2026)

Orthofix Medical has disclosed Other Accumulated Expenses across 17 years of filings, most recently posting $106.2 million for Q1 2026.

• Quarterly Other Accumulated Expenses rose 8.21% year-over-year to $106.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $106.2 million (up 8.21% YoY) and the FY2025 annual result came in at $111.3 million, down 6.57% from the prior year.
• Other Accumulated Expenses eased to $106.2 million in Q1 2026, from $111.3 million in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $119.1 million in Q4 2024 and troughed at $48.2 million in Q2 2022.
• A 5-year average of $90.6 million and a median of $98.6 million in 2023 frame the typical range for Other Accumulated Expenses.
• Annual changes were most pronounced in 2022 — Other Accumulated Expenses declined 27.88% — and 2023, when it soared 101.15%.
• Tracing OFIX's Other Accumulated Expenses over 5 years: stood at $55.4 million in 2022, then jumped by 89.45% to $104.9 million in 2023, then increased by 13.5% to $119.1 million in 2024, then decreased by 6.57% to $111.3 million in 2025, then retreated by 4.51% to $106.2 million in 2026.
• Business Quant data shows OFIX's Other Accumulated Expenses at $106.2 million in Q1 2026, $111.3 million in Q4 2025, and $108.6 million in Q3 2025.